Researches

Displaying 421 - 430 of 4050
# Title Department Research Year
421 New pyrimidine/thiazole hybrids endowed with analgesic, anti-inflammatory, and lower cardiotoxic activities: Design, synthesis, and COX-2/sEH dual inhibition Department of Pharmaceutical Organic Chemistry 2022
422 Novel Azine Linked Hybrids of 2-indolinone and Thiazolodinone Scaffolds as CDK2 Inhibitors with Potential Anticancer Activity: In Silico Design, Synthesis, Biological, Molecular Dynamics and Binding Free Energy Studies Department of Medicinal Chemistry 2022
423 Novel indazole derivatives as potent apoptotic antiproliferative agents by multi-targeted mechanism: Synthesis and biological evaluation Department of Pharmaceutical Organic Chemistry 2022
424 Novel piperine-carboximidamide hybrids: design, synthesis, and antiproliferative activity via a multi-targeted inhibitory pathway Department of Pharmaceutical Organic Chemistry 2022
425 Novel Spiro Hybrids of 2-indolinone and Thiazolodinone Scaffolds as Cell Cycle Checkpoints’ Pathways Regulators with potential anticancer activity Department of Medicinal Chemistry 2022
426 Nucleic acids for gene therapy (book chapter) Department of Pharmaceutics 2022
427 Optimization and SAR investigation of novel 2,3-dihydropyrazino[1,2-a]indole-1,4-dione derivatives as EGFR and BRAFV600E dual inhibitors with potent antiproliferative and antioxidant activities Department of Pharmaceutical Organic Chemistry 2022
428 Perceptions and Attitudes of Hospital’ Prescribers towards Drug Information Sources and Prescribing Practices Department of Clinical Pharmacy 2022
429 Pharmacokinetics and Pharmacodynamics of Dexmedetomidine Administered as an Adjunct to Bupivacaine for Transversus Abdominis Plane Block in Patients Undergoing Lower Abdominal Cancer Surgery Department of Clinical Pharmacy 2022
430 Phytochemical investigation, molecular docking studies and DFT calculations on the antidiabetic and cytotoxic activities of Gmelina philippensis CHAM. Department of Medicinal Chemistry 2022